Literature DB >> 29192130

Transplantation for therapy-related, TP53-mutated myelodysplastic syndrome - not because we can, but because we should.

Corey Cutler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29192130      PMCID: PMC5709095          DOI: 10.3324/haematol.2017.181180

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Authors:  Tetsuichi Yoshizato; Yasuhito Nannya; Yoshiko Atsuta; Yusuke Shiozawa; Yuka Iijima-Yamashita; Kenichi Yoshida; Yuichi Shiraishi; Hiromichi Suzuki; Yasunobu Nagata; Yusuke Sato; Nobuyuki Kakiuchi; Keitaro Matsuo; Makoto Onizuka; Keisuke Kataoka; Kenichi Chiba; Hiroko Tanaka; Hiroo Ueno; Masahiro M Nakagawa; Bartlomiej Przychodzen; Claudia Haferlach; Wolfgang Kern; Kosuke Aoki; Hidehiro Itonaga; Yoshinobu Kanda; Mikkael A Sekeres; Jaroslaw P Maciejewski; Torsten Haferlach; Yasushi Miyazaki; Keizo Horibe; Masashi Sanada; Satoru Miyano; Hideki Makishima; Seishi Ogawa
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

2.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

Authors:  R Coleman Lindsley; Wael Saber; Brenton G Mar; Robert Redd; Tao Wang; Michael D Haagenson; Peter V Grauman; Zhen-Huan Hu; Stephen R Spellman; Stephanie J Lee; Michael R Verneris; Katharine Hsu; Katharina Fleischhauer; Corey Cutler; Joseph H Antin; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

3.  Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

Authors:  Rafael Bejar; Kristen E Stevenson; Bennett Caughey; R Coleman Lindsley; Brenton G Mar; Petar Stojanov; Gad Getz; David P Steensma; Jerome Ritz; Robert Soiffer; Joseph H Antin; Edwin Alyea; Philippe Armand; Vincent Ho; John Koreth; Donna Neuberg; Corey S Cutler; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2014-08-04       Impact factor: 44.544

4.  TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Authors:  John S Welch; Allegra A Petti; Christopher A Miller; Catrina C Fronick; Michelle O'Laughlin; Robert S Fulton; Richard K Wilson; Jack D Baty; Eric J Duncavage; Bevan Tandon; Yi-Shan Lee; Lukas D Wartman; Geoffrey L Uy; Armin Ghobadi; Michael H Tomasson; Iskra Pusic; Rizwan Romee; Todd A Fehniger; Keith E Stockerl-Goldstein; Ravi Vij; Stephen T Oh; Camille N Abboud; Amanda F Cashen; Mark A Schroeder; Meagan A Jacoby; Sharon E Heath; Kierstin Luber; Megan R Janke; Andrew Hantel; Niloufer Khan; Madina J Sukhanova; Randall W Knoebel; Wendy Stock; Timothy A Graubert; Matthew J Walter; Peter Westervelt; Daniel C Link; John F DiPersio; Timothy J Ley
Journal:  N Engl J Med       Date:  2016-11-24       Impact factor: 91.245

5.  Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Matteo G Della Porta; Anna Gallì; Andrea Bacigalupo; Silvia Zibellini; Massimo Bernardi; Ettore Rizzo; Bernardino Allione; Maria Teresa van Lint; Pietro Pioltelli; Paola Marenco; Alberto Bosi; Maria Teresa Voso; Simona Sica; Mariella Cuzzola; Emanuele Angelucci; Marianna Rossi; Marta Ubezio; Alberto Malovini; Ivan Limongelli; Virginia V Ferretti; Orietta Spinelli; Cristina Tresoldi; Sarah Pozzi; Silvia Luchetti; Laura Pezzetti; Silvia Catricalà; Chiara Milanesi; Alberto Riva; Benedetto Bruno; Fabio Ciceri; Francesca Bonifazi; Riccardo Bellazzi; Elli Papaemmanuil; Armando Santoro; Emilio P Alessandrino; Alessandro Rambaldi; Mario Cazzola
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

6.  Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.

Authors:  Ibrahim Aldoss; Anh Pham; Sierra Min Li; Ketevan Gendzekhadze; Michelle Afkhami; Milhan Telatar; Hao Hong; Abbas Padeganeh; Victoria Bedell; Thai Cao; Samer K Khaled; Monzr M Al Malki; Amandeep Salhotra; Haris Ali; Ahmed Aribi; Joycelynne Palmer; Patricia Aoun; Ricardo Spielberger; Anthony S Stein; David Snyder; Margaret R O'Donnell; Joyce Murata-Collins; David Senitzer; Dennis Weisenburger; Stephen J Forman; Vinod Pullarkat; Guido Marcucci; Raju Pillai; Ryotaro Nakamura
Journal:  Haematologica       Date:  2017-09-29       Impact factor: 9.941

  6 in total
  2 in total

Review 1.  Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.

Authors:  Alexandra Higgins; Mithun Vinod Shah
Journal:  Genes (Basel)       Date:  2020-07-06       Impact factor: 4.096

2.  Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.

Authors:  Justin Loke; Myriam Labopin; Charles Craddock; Jan J Cornelissen; Hélène Labussière-Wallet; Eva Maria Wagner-Drouet; Gwendolyn Van Gorkom; Nicolaas P M Schaap; Nicolaus M Kröger; Joan Hendrik Veelken; Montserrat Rovira; Anne Lise Menard; Gesine Bug; Ali Bazarbachi; Sebastian Giebel; Eolia Brissot; Arnon Nagler; Jordi Esteve; Mohamad Mohty
Journal:  Cancer       Date:  2022-05-25       Impact factor: 6.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.